Global Oral Anti-Diabetic Drug Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Oral Anti-Diabetic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Anti-Diabetic Drug.
The Oral Anti-Diabetic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oral Anti-Diabetic Drug market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Anti-Diabetic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Anti-Diabetic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Anti-Diabetic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Oral Anti-Diabetic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oral Anti-Diabetic Drug market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Anti-Diabetic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
- Takeda
- Pfizer
- Eli Lilly
- Janssen Pharmaceuticals
- Astellas
- Boehringer Ingelheim
- Merck And Co.
- AstraZeneca
- Bristol Myers Squibb
- Novartis
- Sanofi
- Abbott
- Biocon
- Glimepiride
- Gliclazide
- Glyburide
- Others
- Hospital
- Research Institual
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- U.A.E
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Anti-Diabetic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Anti-Diabetic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 ORAL ANTI-DIABETIC DRUG MARKET OVERVIEW
1.1 Product Overview and Scope of Oral Anti-Diabetic Drug
1.2 Oral Anti-Diabetic Drug Segment by Type
1.2.1 Global Oral Anti-Diabetic Drug Market Value Comparison by Type (2023-2029)
1.2.2 Glimepiride
1.2.3 Gliclazide
1.2.4 Glyburide
1.2.5 Others
1.3 Oral Anti-Diabetic Drug Segment by Application
1.3.1 Global Oral Anti-Diabetic Drug Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Research Institual
1.4 Global Oral Anti-Diabetic Drug Market Size Estimates and Forecasts
1.4.1 Global Oral Anti-Diabetic Drug Revenue 2018-2029
1.4.2 Global Oral Anti-Diabetic Drug Sales 2018-2029
1.4.3 Global Oral Anti-Diabetic Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 ORAL ANTI-DIABETIC DRUG MARKET COMPETITION BY MANUFACTURERS
2.1 Global Oral Anti-Diabetic Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oral Anti-Diabetic Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oral Anti-Diabetic Drug Average Price by Manufacturers (2018-2023)
2.4 Global Oral Anti-Diabetic Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oral Anti-Diabetic Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Anti-Diabetic Drug, Product Type & Application
2.7 Oral Anti-Diabetic Drug Market Competitive Situation and Trends
2.7.1 Oral Anti-Diabetic Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Anti-Diabetic Drug Players Market Share by Revenue
2.7.3 Global Oral Anti-Diabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 ORAL ANTI-DIABETIC DRUG RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Oral Anti-Diabetic Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral Anti-Diabetic Drug Global Oral Anti-Diabetic Drug Sales by Region: 2018-2029
3.2.1 Global Oral Anti-Diabetic Drug Sales by Region: 2018-2023
3.2.2 Global Oral Anti-Diabetic Drug Sales by Region: 2024-2029
3.3 Global Oral Anti-Diabetic Drug Global Oral Anti-Diabetic Drug Revenue by Region: 2018-2029
3.3.1 Global Oral Anti-Diabetic Drug Revenue by Region: 2018-2023
3.3.2 Global Oral Anti-Diabetic Drug Revenue by Region: 2024-2029
3.4 North America Oral Anti-Diabetic Drug Market Facts & Figures by Country
3.4.1 North America Oral Anti-Diabetic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral Anti-Diabetic Drug Sales by Country (2018-2029)
3.4.3 North America Oral Anti-Diabetic Drug Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Anti-Diabetic Drug Market Facts & Figures by Country
3.5.1 Europe Oral Anti-Diabetic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral Anti-Diabetic Drug Sales by Country (2018-2029)
3.5.3 Europe Oral Anti-Diabetic Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Anti-Diabetic Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Anti-Diabetic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral Anti-Diabetic Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral Anti-Diabetic Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Anti-Diabetic Drug Market Facts & Figures by Country
3.7.1 Latin America Oral Anti-Diabetic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral Anti-Diabetic Drug Sales by Country (2018-2029)
3.7.3 Latin America Oral Anti-Diabetic Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Anti-Diabetic Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Anti-Diabetic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral Anti-Diabetic Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral Anti-Diabetic Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 SEGMENT BY TYPE
4.1 Global Oral Anti-Diabetic Drug Sales by Type (2018-2029)
4.1.1 Global Oral Anti-Diabetic Drug Sales by Type (2018-2023)
4.1.2 Global Oral Anti-Diabetic Drug Sales by Type (2024-2029)
4.1.3 Global Oral Anti-Diabetic Drug Sales Market Share by Type (2018-2029)
4.2 Global Oral Anti-Diabetic Drug Revenue by Type (2018-2029)
4.2.1 Global Oral Anti-Diabetic Drug Revenue by Type (2018-2023)
4.2.2 Global Oral Anti-Diabetic Drug Revenue by Type (2024-2029)
4.2.3 Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2018-2029)
4.3 Global Oral Anti-Diabetic Drug Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Oral Anti-Diabetic Drug Sales by Application (2018-2029)
5.1.1 Global Oral Anti-Diabetic Drug Sales by Application (2018-2023)
5.1.2 Global Oral Anti-Diabetic Drug Sales by Application (2024-2029)
5.1.3 Global Oral Anti-Diabetic Drug Sales Market Share by Application (2018-2029)
5.2 Global Oral Anti-Diabetic Drug Revenue by Application (2018-2029)
5.2.1 Global Oral Anti-Diabetic Drug Revenue by Application (2018-2023)
5.2.2 Global Oral Anti-Diabetic Drug Revenue by Application (2024-2029)
5.2.3 Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2018-2029)
5.3 Global Oral Anti-Diabetic Drug Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Takeda Oral Anti-Diabetic Drug Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Oral Anti-Diabetic Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lilly Oral Anti-Diabetic Drug Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Janssen Pharmaceuticals
6.4.1 Janssen Pharmaceuticals Corporation Information
6.4.2 Janssen Pharmaceuticals Description and Business Overview
6.4.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product Portfolio
6.4.5 Janssen Pharmaceuticals Recent Developments/Updates
6.5 Astellas
6.5.1 Astellas Corporation Information
6.5.2 Astellas Description and Business Overview
6.5.3 Astellas Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Astellas Oral Anti-Diabetic Drug Product Portfolio
6.5.5 Astellas Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Boehringer Ingelheim Oral Anti-Diabetic Drug Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Merck And Co.
6.6.1 Merck And Co. Corporation Information
6.6.2 Merck And Co. Description and Business Overview
6.6.3 Merck And Co. Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck And Co. Oral Anti-Diabetic Drug Product Portfolio
6.7.5 Merck And Co. Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AstraZeneca Oral Anti-Diabetic Drug Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Bristol Myers Squibb
6.9.1 Bristol Myers Squibb Corporation Information
6.9.2 Bristol Myers Squibb Description and Business Overview
6.9.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bristol Myers Squibb Oral Anti-Diabetic Drug Product Portfolio
6.9.5 Bristol Myers Squibb Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Novartis Oral Anti-Diabetic Drug Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Corporation Information
6.11.2 Sanofi Oral Anti-Diabetic Drug Description and Business Overview
6.11.3 Sanofi Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sanofi Oral Anti-Diabetic Drug Product Portfolio
6.11.5 Sanofi Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Oral Anti-Diabetic Drug Description and Business Overview
6.12.3 Abbott Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Abbott Oral Anti-Diabetic Drug Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Biocon
6.13.1 Biocon Corporation Information
6.13.2 Biocon Oral Anti-Diabetic Drug Description and Business Overview
6.13.3 Biocon Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Biocon Oral Anti-Diabetic Drug Product Portfolio
6.13.5 Biocon Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Oral Anti-Diabetic Drug Industry Chain Analysis
7.2 Oral Anti-Diabetic Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Anti-Diabetic Drug Production Mode & Process
7.4 Oral Anti-Diabetic Drug Sales and Marketing
7.4.1 Oral Anti-Diabetic Drug Sales Channels
7.4.2 Oral Anti-Diabetic Drug Distributors
7.5 Oral Anti-Diabetic Drug Customers
8 ORAL ANTI-DIABETIC DRUG MARKET DYNAMICS
8.1 Oral Anti-Diabetic Drug Industry Trends
8.2 Oral Anti-Diabetic Drug Market Drivers
8.3 Oral Anti-Diabetic Drug Market Challenges
8.4 Oral Anti-Diabetic Drug Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Oral Anti-Diabetic Drug
1.2 Oral Anti-Diabetic Drug Segment by Type
1.2.1 Global Oral Anti-Diabetic Drug Market Value Comparison by Type (2023-2029)
1.2.2 Glimepiride
1.2.3 Gliclazide
1.2.4 Glyburide
1.2.5 Others
1.3 Oral Anti-Diabetic Drug Segment by Application
1.3.1 Global Oral Anti-Diabetic Drug Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Research Institual
1.4 Global Oral Anti-Diabetic Drug Market Size Estimates and Forecasts
1.4.1 Global Oral Anti-Diabetic Drug Revenue 2018-2029
1.4.2 Global Oral Anti-Diabetic Drug Sales 2018-2029
1.4.3 Global Oral Anti-Diabetic Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 ORAL ANTI-DIABETIC DRUG MARKET COMPETITION BY MANUFACTURERS
2.1 Global Oral Anti-Diabetic Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oral Anti-Diabetic Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oral Anti-Diabetic Drug Average Price by Manufacturers (2018-2023)
2.4 Global Oral Anti-Diabetic Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oral Anti-Diabetic Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Anti-Diabetic Drug, Product Type & Application
2.7 Oral Anti-Diabetic Drug Market Competitive Situation and Trends
2.7.1 Oral Anti-Diabetic Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Anti-Diabetic Drug Players Market Share by Revenue
2.7.3 Global Oral Anti-Diabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 ORAL ANTI-DIABETIC DRUG RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Oral Anti-Diabetic Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral Anti-Diabetic Drug Global Oral Anti-Diabetic Drug Sales by Region: 2018-2029
3.2.1 Global Oral Anti-Diabetic Drug Sales by Region: 2018-2023
3.2.2 Global Oral Anti-Diabetic Drug Sales by Region: 2024-2029
3.3 Global Oral Anti-Diabetic Drug Global Oral Anti-Diabetic Drug Revenue by Region: 2018-2029
3.3.1 Global Oral Anti-Diabetic Drug Revenue by Region: 2018-2023
3.3.2 Global Oral Anti-Diabetic Drug Revenue by Region: 2024-2029
3.4 North America Oral Anti-Diabetic Drug Market Facts & Figures by Country
3.4.1 North America Oral Anti-Diabetic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral Anti-Diabetic Drug Sales by Country (2018-2029)
3.4.3 North America Oral Anti-Diabetic Drug Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Anti-Diabetic Drug Market Facts & Figures by Country
3.5.1 Europe Oral Anti-Diabetic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral Anti-Diabetic Drug Sales by Country (2018-2029)
3.5.3 Europe Oral Anti-Diabetic Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Anti-Diabetic Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Anti-Diabetic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral Anti-Diabetic Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral Anti-Diabetic Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Anti-Diabetic Drug Market Facts & Figures by Country
3.7.1 Latin America Oral Anti-Diabetic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral Anti-Diabetic Drug Sales by Country (2018-2029)
3.7.3 Latin America Oral Anti-Diabetic Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Anti-Diabetic Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Anti-Diabetic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral Anti-Diabetic Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral Anti-Diabetic Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 SEGMENT BY TYPE
4.1 Global Oral Anti-Diabetic Drug Sales by Type (2018-2029)
4.1.1 Global Oral Anti-Diabetic Drug Sales by Type (2018-2023)
4.1.2 Global Oral Anti-Diabetic Drug Sales by Type (2024-2029)
4.1.3 Global Oral Anti-Diabetic Drug Sales Market Share by Type (2018-2029)
4.2 Global Oral Anti-Diabetic Drug Revenue by Type (2018-2029)
4.2.1 Global Oral Anti-Diabetic Drug Revenue by Type (2018-2023)
4.2.2 Global Oral Anti-Diabetic Drug Revenue by Type (2024-2029)
4.2.3 Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2018-2029)
4.3 Global Oral Anti-Diabetic Drug Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Oral Anti-Diabetic Drug Sales by Application (2018-2029)
5.1.1 Global Oral Anti-Diabetic Drug Sales by Application (2018-2023)
5.1.2 Global Oral Anti-Diabetic Drug Sales by Application (2024-2029)
5.1.3 Global Oral Anti-Diabetic Drug Sales Market Share by Application (2018-2029)
5.2 Global Oral Anti-Diabetic Drug Revenue by Application (2018-2029)
5.2.1 Global Oral Anti-Diabetic Drug Revenue by Application (2018-2023)
5.2.2 Global Oral Anti-Diabetic Drug Revenue by Application (2024-2029)
5.2.3 Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2018-2029)
5.3 Global Oral Anti-Diabetic Drug Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Takeda Oral Anti-Diabetic Drug Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Oral Anti-Diabetic Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lilly Oral Anti-Diabetic Drug Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Janssen Pharmaceuticals
6.4.1 Janssen Pharmaceuticals Corporation Information
6.4.2 Janssen Pharmaceuticals Description and Business Overview
6.4.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product Portfolio
6.4.5 Janssen Pharmaceuticals Recent Developments/Updates
6.5 Astellas
6.5.1 Astellas Corporation Information
6.5.2 Astellas Description and Business Overview
6.5.3 Astellas Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Astellas Oral Anti-Diabetic Drug Product Portfolio
6.5.5 Astellas Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Boehringer Ingelheim Oral Anti-Diabetic Drug Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Merck And Co.
6.6.1 Merck And Co. Corporation Information
6.6.2 Merck And Co. Description and Business Overview
6.6.3 Merck And Co. Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck And Co. Oral Anti-Diabetic Drug Product Portfolio
6.7.5 Merck And Co. Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AstraZeneca Oral Anti-Diabetic Drug Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Bristol Myers Squibb
6.9.1 Bristol Myers Squibb Corporation Information
6.9.2 Bristol Myers Squibb Description and Business Overview
6.9.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bristol Myers Squibb Oral Anti-Diabetic Drug Product Portfolio
6.9.5 Bristol Myers Squibb Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Novartis Oral Anti-Diabetic Drug Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Corporation Information
6.11.2 Sanofi Oral Anti-Diabetic Drug Description and Business Overview
6.11.3 Sanofi Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sanofi Oral Anti-Diabetic Drug Product Portfolio
6.11.5 Sanofi Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Oral Anti-Diabetic Drug Description and Business Overview
6.12.3 Abbott Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Abbott Oral Anti-Diabetic Drug Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Biocon
6.13.1 Biocon Corporation Information
6.13.2 Biocon Oral Anti-Diabetic Drug Description and Business Overview
6.13.3 Biocon Oral Anti-Diabetic Drug Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Biocon Oral Anti-Diabetic Drug Product Portfolio
6.13.5 Biocon Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Oral Anti-Diabetic Drug Industry Chain Analysis
7.2 Oral Anti-Diabetic Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Anti-Diabetic Drug Production Mode & Process
7.4 Oral Anti-Diabetic Drug Sales and Marketing
7.4.1 Oral Anti-Diabetic Drug Sales Channels
7.4.2 Oral Anti-Diabetic Drug Distributors
7.5 Oral Anti-Diabetic Drug Customers
8 ORAL ANTI-DIABETIC DRUG MARKET DYNAMICS
8.1 Oral Anti-Diabetic Drug Industry Trends
8.2 Oral Anti-Diabetic Drug Market Drivers
8.3 Oral Anti-Diabetic Drug Market Challenges
8.4 Oral Anti-Diabetic Drug Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Oral Anti-Diabetic Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Oral Anti-Diabetic Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Oral Anti-Diabetic Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Oral Anti-Diabetic Drug Sales (K Tons) of Key Manufacturers (2018-2023)
Table 5. Global Oral Anti-Diabetic Drug Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Oral Anti-Diabetic Drug Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Oral Anti-Diabetic Drug Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Oral Anti-Diabetic Drug Average Price (USD/Ton) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Oral Anti-Diabetic Drug, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Oral Anti-Diabetic Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Anti-Diabetic Drug, Product Type & Application
Table 12. Global Key Manufacturers of Oral Anti-Diabetic Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Anti-Diabetic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anti-Diabetic Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Anti-Diabetic Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Oral Anti-Diabetic Drug Sales by Region (2018-2023) & (K Tons)
Table 18. Global Oral Anti-Diabetic Drug Sales Market Share by Region (2018-2023)
Table 19. Global Oral Anti-Diabetic Drug Sales by Region (2024-2029) & (K Tons)
Table 20. Global Oral Anti-Diabetic Drug Sales Market Share by Region (2024-2029)
Table 21. Global Oral Anti-Diabetic Drug Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Oral Anti-Diabetic Drug Revenue Market Share by Region (2018-2023)
Table 23. Global Oral Anti-Diabetic Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Oral Anti-Diabetic Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Oral Anti-Diabetic Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Oral Anti-Diabetic Drug Sales by Country (2018-2023) & (K Tons)
Table 27. North America Oral Anti-Diabetic Drug Sales by Country (2024-2029) & (K Tons)
Table 28. North America Oral Anti-Diabetic Drug Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Oral Anti-Diabetic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Oral Anti-Diabetic Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Oral Anti-Diabetic Drug Sales by Country (2018-2023) & (K Tons)
Table 32. Europe Oral Anti-Diabetic Drug Sales by Country (2024-2029) & (K Tons)
Table 33. Europe Oral Anti-Diabetic Drug Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Oral Anti-Diabetic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Oral Anti-Diabetic Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Oral Anti-Diabetic Drug Sales by Region (2018-2023) & (K Tons)
Table 37. Asia Pacific Oral Anti-Diabetic Drug Sales by Region (2024-2029) & (K Tons)
Table 38. Asia Pacific Oral Anti-Diabetic Drug Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Oral Anti-Diabetic Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Oral Anti-Diabetic Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Oral Anti-Diabetic Drug Sales by Country (2018-2023) & (K Tons)
Table 42. Latin America Oral Anti-Diabetic Drug Sales by Country (2024-2029) & (K Tons)
Table 43. Latin America Oral Anti-Diabetic Drug Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Oral Anti-Diabetic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Oral Anti-Diabetic Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Oral Anti-Diabetic Drug Sales by Country (2018-2023) & (K Tons)
Table 47. Middle East & Africa Oral Anti-Diabetic Drug Sales by Country (2024-2029) & (K Tons)
Table 48. Middle East & Africa Oral Anti-Diabetic Drug Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Oral Anti-Diabetic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Oral Anti-Diabetic Drug Sales (K Tons) by Type (2018-2023)
Table 51. Global Oral Anti-Diabetic Drug Sales (K Tons) by Type (2024-2029)
Table 52. Global Oral Anti-Diabetic Drug Sales Market Share by Type (2018-2023)
Table 53. Global Oral Anti-Diabetic Drug Sales Market Share by Type (2024-2029)
Table 54. Global Oral Anti-Diabetic Drug Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Oral Anti-Diabetic Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2018-2023)
Table 57. Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Oral Anti-Diabetic Drug Price (USD/Ton) by Type (2018-2023)
Table 59. Global Oral Anti-Diabetic Drug Price (USD/Ton) by Type (2024-2029)
Table 60. Global Oral Anti-Diabetic Drug Sales (K Tons) by Application (2018-2023)
Table 61. Global Oral Anti-Diabetic Drug Sales (K Tons) by Application (2024-2029)
Table 62. Global Oral Anti-Diabetic Drug Sales Market Share by Application (2018-2023)
Table 63. Global Oral Anti-Diabetic Drug Sales Market Share by Application (2024-2029)
Table 64. Global Oral Anti-Diabetic Drug Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Oral Anti-Diabetic Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2018-2023)
Table 67. Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Oral Anti-Diabetic Drug Price (USD/Ton) by Application (2018-2023)
Table 69. Global Oral Anti-Diabetic Drug Price (USD/Ton) by Application (2024-2029)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 73. Takeda Oral Anti-Diabetic Drug Product
Table 74. Takeda Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 78. Pfizer Oral Anti-Diabetic Drug Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 83. Eli Lilly Oral Anti-Diabetic Drug Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Janssen Pharmaceuticals Corporation Information
Table 86. Janssen Pharmaceuticals Description and Business Overview
Table 87. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 88. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product
Table 89. Janssen Pharmaceuticals Recent Developments/Updates
Table 90. Astellas Corporation Information
Table 91. Astellas Description and Business Overview
Table 92. Astellas Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 93. Astellas Oral Anti-Diabetic Drug Product
Table 94. Astellas Recent Developments/Updates
Table 95. Boehringer Ingelheim Corporation Information
Table 96. Boehringer Ingelheim Description and Business Overview
Table 97. Boehringer Ingelheim Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 98. Boehringer Ingelheim Oral Anti-Diabetic Drug Product
Table 99. Boehringer Ingelheim Recent Developments/Updates
Table 100. Merck And Co. Corporation Information
Table 101. Merck And Co. Description and Business Overview
Table 102. Merck And Co. Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 103. Merck And Co. Oral Anti-Diabetic Drug Product
Table 104. Merck And Co. Recent Developments/Updates
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 108. AstraZeneca Oral Anti-Diabetic Drug Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Bristol Myers Squibb Corporation Information
Table 111. Bristol Myers Squibb Description and Business Overview
Table 112. Bristol Myers Squibb Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 113. Bristol Myers Squibb Oral Anti-Diabetic Drug Product
Table 114. Bristol Myers Squibb Recent Developments/Updates
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 118. Novartis Oral Anti-Diabetic Drug Product
Table 119. Novartis Recent Developments/Updates
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 123. Sanofi Oral Anti-Diabetic Drug Product
Table 124. Sanofi Recent Developments/Updates
Table 125. Abbott Corporation Information
Table 126. Abbott Description and Business Overview
Table 127. Abbott Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 128. Abbott Oral Anti-Diabetic Drug Product
Table 129. Abbott Recent Developments/Updates
Table 130. Biocon Corporation Information
Table 131. Biocon Description and Business Overview
Table 132. Biocon Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 133. Biocon Oral Anti-Diabetic Drug Product
Table 134. Biocon Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Oral Anti-Diabetic Drug Distributors List
Table 138. Oral Anti-Diabetic Drug Customers List
Table 139. Oral Anti-Diabetic Drug Market Trends
Table 140. Oral Anti-Diabetic Drug Market Drivers
Table 141. Oral Anti-Diabetic Drug Market Challenges
Table 142. Oral Anti-Diabetic Drug Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 1. Global Oral Anti-Diabetic Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Oral Anti-Diabetic Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Oral Anti-Diabetic Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Oral Anti-Diabetic Drug Sales (K Tons) of Key Manufacturers (2018-2023)
Table 5. Global Oral Anti-Diabetic Drug Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Oral Anti-Diabetic Drug Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Oral Anti-Diabetic Drug Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Oral Anti-Diabetic Drug Average Price (USD/Ton) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Oral Anti-Diabetic Drug, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Oral Anti-Diabetic Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Anti-Diabetic Drug, Product Type & Application
Table 12. Global Key Manufacturers of Oral Anti-Diabetic Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Anti-Diabetic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anti-Diabetic Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Anti-Diabetic Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Oral Anti-Diabetic Drug Sales by Region (2018-2023) & (K Tons)
Table 18. Global Oral Anti-Diabetic Drug Sales Market Share by Region (2018-2023)
Table 19. Global Oral Anti-Diabetic Drug Sales by Region (2024-2029) & (K Tons)
Table 20. Global Oral Anti-Diabetic Drug Sales Market Share by Region (2024-2029)
Table 21. Global Oral Anti-Diabetic Drug Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Oral Anti-Diabetic Drug Revenue Market Share by Region (2018-2023)
Table 23. Global Oral Anti-Diabetic Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Oral Anti-Diabetic Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Oral Anti-Diabetic Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Oral Anti-Diabetic Drug Sales by Country (2018-2023) & (K Tons)
Table 27. North America Oral Anti-Diabetic Drug Sales by Country (2024-2029) & (K Tons)
Table 28. North America Oral Anti-Diabetic Drug Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Oral Anti-Diabetic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Oral Anti-Diabetic Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Oral Anti-Diabetic Drug Sales by Country (2018-2023) & (K Tons)
Table 32. Europe Oral Anti-Diabetic Drug Sales by Country (2024-2029) & (K Tons)
Table 33. Europe Oral Anti-Diabetic Drug Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Oral Anti-Diabetic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Oral Anti-Diabetic Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Oral Anti-Diabetic Drug Sales by Region (2018-2023) & (K Tons)
Table 37. Asia Pacific Oral Anti-Diabetic Drug Sales by Region (2024-2029) & (K Tons)
Table 38. Asia Pacific Oral Anti-Diabetic Drug Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Oral Anti-Diabetic Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Oral Anti-Diabetic Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Oral Anti-Diabetic Drug Sales by Country (2018-2023) & (K Tons)
Table 42. Latin America Oral Anti-Diabetic Drug Sales by Country (2024-2029) & (K Tons)
Table 43. Latin America Oral Anti-Diabetic Drug Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Oral Anti-Diabetic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Oral Anti-Diabetic Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Oral Anti-Diabetic Drug Sales by Country (2018-2023) & (K Tons)
Table 47. Middle East & Africa Oral Anti-Diabetic Drug Sales by Country (2024-2029) & (K Tons)
Table 48. Middle East & Africa Oral Anti-Diabetic Drug Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Oral Anti-Diabetic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Oral Anti-Diabetic Drug Sales (K Tons) by Type (2018-2023)
Table 51. Global Oral Anti-Diabetic Drug Sales (K Tons) by Type (2024-2029)
Table 52. Global Oral Anti-Diabetic Drug Sales Market Share by Type (2018-2023)
Table 53. Global Oral Anti-Diabetic Drug Sales Market Share by Type (2024-2029)
Table 54. Global Oral Anti-Diabetic Drug Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Oral Anti-Diabetic Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2018-2023)
Table 57. Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Oral Anti-Diabetic Drug Price (USD/Ton) by Type (2018-2023)
Table 59. Global Oral Anti-Diabetic Drug Price (USD/Ton) by Type (2024-2029)
Table 60. Global Oral Anti-Diabetic Drug Sales (K Tons) by Application (2018-2023)
Table 61. Global Oral Anti-Diabetic Drug Sales (K Tons) by Application (2024-2029)
Table 62. Global Oral Anti-Diabetic Drug Sales Market Share by Application (2018-2023)
Table 63. Global Oral Anti-Diabetic Drug Sales Market Share by Application (2024-2029)
Table 64. Global Oral Anti-Diabetic Drug Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Oral Anti-Diabetic Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2018-2023)
Table 67. Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Oral Anti-Diabetic Drug Price (USD/Ton) by Application (2018-2023)
Table 69. Global Oral Anti-Diabetic Drug Price (USD/Ton) by Application (2024-2029)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 73. Takeda Oral Anti-Diabetic Drug Product
Table 74. Takeda Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 78. Pfizer Oral Anti-Diabetic Drug Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 83. Eli Lilly Oral Anti-Diabetic Drug Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Janssen Pharmaceuticals Corporation Information
Table 86. Janssen Pharmaceuticals Description and Business Overview
Table 87. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 88. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product
Table 89. Janssen Pharmaceuticals Recent Developments/Updates
Table 90. Astellas Corporation Information
Table 91. Astellas Description and Business Overview
Table 92. Astellas Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 93. Astellas Oral Anti-Diabetic Drug Product
Table 94. Astellas Recent Developments/Updates
Table 95. Boehringer Ingelheim Corporation Information
Table 96. Boehringer Ingelheim Description and Business Overview
Table 97. Boehringer Ingelheim Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 98. Boehringer Ingelheim Oral Anti-Diabetic Drug Product
Table 99. Boehringer Ingelheim Recent Developments/Updates
Table 100. Merck And Co. Corporation Information
Table 101. Merck And Co. Description and Business Overview
Table 102. Merck And Co. Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 103. Merck And Co. Oral Anti-Diabetic Drug Product
Table 104. Merck And Co. Recent Developments/Updates
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 108. AstraZeneca Oral Anti-Diabetic Drug Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Bristol Myers Squibb Corporation Information
Table 111. Bristol Myers Squibb Description and Business Overview
Table 112. Bristol Myers Squibb Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 113. Bristol Myers Squibb Oral Anti-Diabetic Drug Product
Table 114. Bristol Myers Squibb Recent Developments/Updates
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 118. Novartis Oral Anti-Diabetic Drug Product
Table 119. Novartis Recent Developments/Updates
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 123. Sanofi Oral Anti-Diabetic Drug Product
Table 124. Sanofi Recent Developments/Updates
Table 125. Abbott Corporation Information
Table 126. Abbott Description and Business Overview
Table 127. Abbott Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 128. Abbott Oral Anti-Diabetic Drug Product
Table 129. Abbott Recent Developments/Updates
Table 130. Biocon Corporation Information
Table 131. Biocon Description and Business Overview
Table 132. Biocon Oral Anti-Diabetic Drug Sales (K Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2018-2023)
Table 133. Biocon Oral Anti-Diabetic Drug Product
Table 134. Biocon Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Oral Anti-Diabetic Drug Distributors List
Table 138. Oral Anti-Diabetic Drug Customers List
Table 139. Oral Anti-Diabetic Drug Market Trends
Table 140. Oral Anti-Diabetic Drug Market Drivers
Table 141. Oral Anti-Diabetic Drug Market Challenges
Table 142. Oral Anti-Diabetic Drug Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Oral Anti-Diabetic Drug
Figure 2. Global Oral Anti-Diabetic Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Oral Anti-Diabetic Drug Market Share by Type in 2022 & 2029
Figure 4. Glimepiride Product Picture
Figure 5. Gliclazide Product Picture
Figure 6. Glyburide Product Picture
Figure 7. Others Product Picture
Figure 8. Global Oral Anti-Diabetic Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Oral Anti-Diabetic Drug Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Research Institual
Figure 12. Global Oral Anti-Diabetic Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Oral Anti-Diabetic Drug Market Size (2018-2029) & (US$ Million)
Figure 14. Global Oral Anti-Diabetic Drug Sales (2018-2029) & (K Tons)
Figure 15. Global Oral Anti-Diabetic Drug Average Price (USD/Ton) & (2018-2029)
Figure 16. Oral Anti-Diabetic Drug Report Years Considered
Figure 17. Oral Anti-Diabetic Drug Sales Share by Manufacturers in 2022
Figure 18. Global Oral Anti-Diabetic Drug Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Oral Anti-Diabetic Drug Players: Market Share by Revenue in 2022
Figure 20. Oral Anti-Diabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Oral Anti-Diabetic Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Oral Anti-Diabetic Drug Sales Market Share by Country (2018-2029)
Figure 23. North America Oral Anti-Diabetic Drug Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Oral Anti-Diabetic Drug Sales Market Share by Country (2018-2029)
Figure 27. Europe Oral Anti-Diabetic Drug Revenue Market Share by Country (2018-2029)
Figure 28. Germany Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Oral Anti-Diabetic Drug Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Oral Anti-Diabetic Drug Revenue Market Share by Region (2018-2029)
Figure 35. China Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Oral Anti-Diabetic Drug Sales Market Share by Country (2018-2029)
Figure 46. Latin America Oral Anti-Diabetic Drug Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Oral Anti-Diabetic Drug Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Oral Anti-Diabetic Drug Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. U.A.E Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Oral Anti-Diabetic Drug by Type (2018-2029)
Figure 56. Global Revenue Market Share of Oral Anti-Diabetic Drug by Type (2018-2029)
Figure 57. Global Oral Anti-Diabetic Drug Price (USD/Ton) by Type (2018-2029)
Figure 58. Global Sales Market Share of Oral Anti-Diabetic Drug by Application (2018-2029)
Figure 59. Global Revenue Market Share of Oral Anti-Diabetic Drug by Application (2018-2029)
Figure 60. Global Oral Anti-Diabetic Drug Price (USD/Ton) by Application (2018-2029)
Figure 61. Oral Anti-Diabetic Drug Value Chain
Figure 62. Oral Anti-Diabetic Drug Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Figure 1. Product Picture of Oral Anti-Diabetic Drug
Figure 2. Global Oral Anti-Diabetic Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Oral Anti-Diabetic Drug Market Share by Type in 2022 & 2029
Figure 4. Glimepiride Product Picture
Figure 5. Gliclazide Product Picture
Figure 6. Glyburide Product Picture
Figure 7. Others Product Picture
Figure 8. Global Oral Anti-Diabetic Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Oral Anti-Diabetic Drug Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Research Institual
Figure 12. Global Oral Anti-Diabetic Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Oral Anti-Diabetic Drug Market Size (2018-2029) & (US$ Million)
Figure 14. Global Oral Anti-Diabetic Drug Sales (2018-2029) & (K Tons)
Figure 15. Global Oral Anti-Diabetic Drug Average Price (USD/Ton) & (2018-2029)
Figure 16. Oral Anti-Diabetic Drug Report Years Considered
Figure 17. Oral Anti-Diabetic Drug Sales Share by Manufacturers in 2022
Figure 18. Global Oral Anti-Diabetic Drug Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Oral Anti-Diabetic Drug Players: Market Share by Revenue in 2022
Figure 20. Oral Anti-Diabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Oral Anti-Diabetic Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Oral Anti-Diabetic Drug Sales Market Share by Country (2018-2029)
Figure 23. North America Oral Anti-Diabetic Drug Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Oral Anti-Diabetic Drug Sales Market Share by Country (2018-2029)
Figure 27. Europe Oral Anti-Diabetic Drug Revenue Market Share by Country (2018-2029)
Figure 28. Germany Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Oral Anti-Diabetic Drug Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Oral Anti-Diabetic Drug Revenue Market Share by Region (2018-2029)
Figure 35. China Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Oral Anti-Diabetic Drug Sales Market Share by Country (2018-2029)
Figure 46. Latin America Oral Anti-Diabetic Drug Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Oral Anti-Diabetic Drug Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Oral Anti-Diabetic Drug Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. U.A.E Oral Anti-Diabetic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Oral Anti-Diabetic Drug by Type (2018-2029)
Figure 56. Global Revenue Market Share of Oral Anti-Diabetic Drug by Type (2018-2029)
Figure 57. Global Oral Anti-Diabetic Drug Price (USD/Ton) by Type (2018-2029)
Figure 58. Global Sales Market Share of Oral Anti-Diabetic Drug by Application (2018-2029)
Figure 59. Global Revenue Market Share of Oral Anti-Diabetic Drug by Application (2018-2029)
Figure 60. Global Oral Anti-Diabetic Drug Price (USD/Ton) by Application (2018-2029)
Figure 61. Oral Anti-Diabetic Drug Value Chain
Figure 62. Oral Anti-Diabetic Drug Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
